Two large studies from the University of Southern Denmark (SDU) have found that Ozempic, a widely used medication for type 2 diabetes, may double...

The hormone glucagon-like peptide 1 (GLP-1) is effective in controlling insulin release and reducing appetite. It is marketed as Semaglutide, Ozempic...

A recent study from Taichung Veterans General Hospital suggests that people with a specific type of glaucoma, known as normal-tension glaucoma, have a...

WEDNESDAY, Feb. 26, 2025 -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic...

FRIDAY, Feb. 28, 2025 -- GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has...

Weight-loss drugs could soon be used to treat depression following a landmark study.

TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided

THURSDAY, Feb. 27, 2025 -- For patients with obesity undergoing joint replacement, higher weight loss after initiating antiobesity medications within...

MONDAY, Feb. 24, 2025 (HealthDay news) -- Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips...

Discover how semaglutide aids weight loss in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its severe form,...